TUMOR ANTIGENS RECOGNIZED BY T CELLS AND ANTIBODIES (TUMORIMMUNOLOGY AND IMMUNOTHERAPY SERIES, 1)

Tumor Antigens Recognized by T Cells and Antibodies (Tumorimmunology and Immunotherapy Series, 1)
Publisher: CRC | ISBN: 0415296986 | edition 2003 | PDF | 264 pages | 1,2 mb
Recent advancement in basic growth immunology has led to immunotherapy trials in patients with solidified tumors and hematological malignancies. In the past, immunotherapy approaches were primarily supported on improvement of growth status with cytokines and adjuvant therapy, without noesis of germane growth antigens. The brainstorm of growth antigens confident of eliciting insusceptible responses has today resulted in the utilization of antigen-specific immunotherapy strategies. Vaccination with circumscribed peptide epitopes, pure proteins, radiophone components, and full cells expressing circumscribed growth antigens provides an possibleness to manoeuvre antigen-specific insusceptible responses in vaccinated patients, and to related status with clinical outcome. Tumor Antigens Recognized by T Cells and Antibodies provides a broad overview of the molecular nature of growth antigens that crapper be constituted by antibodies, supporter T lymphocytes and cytotoxic T lymphocytes. Novel strategies to compound impotent status against much antigens wage the foundation for reinforced immunotherapy protocols for enduring treatment. With contributions from a patron of planetary experts in the field, this aggregation provides valuable aggregation for clinicians and researchers with an welfare in cancer immunotherapy.